相关实验视频

Updated: Jun 24, 2026

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation

Published on: November 26, 2018

基因变异及其对边缘区域淋巴瘤的预后影响:一个元分析

Xijing Li¹, Yang Lin², Licai An³

¹Department of Pathology, Yantaishan Hospital, Yantai City, Shandong, 264003, China.

Annals of hematology

|January 17, 2025

概括

NOTCH2和TNFAIP3基因的基因突变显著恶化了边缘区域淋巴瘤 (MZL) 患者的预后,影响了生存率和进展率. 识别这些标志物有助于个性化治疗和MZL的临床前景.

科学领域:

血液学血液学血液学
在瘤学瘤学.
遗传学遗传学是一个

背景情况:

边缘区域淋巴瘤 (MZL) 是一种异质的B细胞恶性瘤.
对MZL的预后因素对于指导治疗策略至关重要.
特定基因突变在MZL预后中的作用需要进一步阐明.

研究的目的:

评估NOTCH2和TNFAIP3基因突变在边缘区域淋巴瘤 (MZL) 患者的预后影响.
分析这些突变与关键生存结果之间的关联.

主要方法:

进行了一项元分析,系统地搜索到2023年10月的PubMed,Embase和Cochrane图书馆.
这项分析包括11项包括2314名患者的研究.
结果措施包括5年总生存率 (OSR),无进展生存率 (PFSR) 和瘤进展率 (TPR).

主要成果:

骨MZL (SMZL) 的NOTCH2突变与5年后的OSR和PFSR显著下降有关.
在SMZL中TNFAIP3突变也显著减少了5年的OSR和PFSR.
眼膜MZL (OA-MZL) 的NOTCH2突变与5年OSR显著下降相关.

结论:

NOTCH2和TNFAIP3基因突变是MZL中显著的负预后指标.
这些遗传变化与较差的生存率和增加的进展有关.
鉴定这些突变可以促进个性化治疗方法,并改善MZL患者的临床预后.

关键词:

遗传变化是一种基因变化.边缘区域淋巴瘤边缘区域淋巴瘤进行元分析分析.预测影响预测的影响.

更多相关视频

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

Enhancing Tumor Content through Tumor Macrodissection

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...